# Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

> **NCT06306638** · PHASE1,PHASE2 · RECRUITING · sponsor: **Roswell Park Cancer Institute** · enrollment: 42 (estimated)

## Conditions studied

- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Endobronchial Ultrasound Bronchoscopy
- **PROCEDURE:** Interstitial Photodynamic Therapy
- **RADIATION:** Palliative Radiation Therapy
- **OTHER:** Physical Performance Testing
- **OTHER:** Questionnaire Administration
- **DRUG:** Verteporfin
- **DEVICE:** Laser: ML7710-PDT

## Key facts

- **NCT ID:** NCT06306638
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2029-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306638, "Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06306638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*